Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

99 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Completed

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

NCT02158858

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Disease, +23 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Northwestern University - Lurie Comprehensive Cancer Center Chicago, Illinois, United States
View all 48 locations
View Trial Details
Completed

Fedratinib in Combination With Nivolumab

NCT05393674

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
  • University Medicine Greifswald Greifswald, Germany
  • Universitätsklinikum Halle (Saale) Halle, Germany
  • Medizinische Hochschule Hanover, Germany
View Trial Details
Completed

An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005)

NCT05223920

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • University of Miami Leonard M. Miller Miami, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • UMPC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View all 19 locations
View Trial Details
Completed

An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

NCT03952039

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Local Institution - 103 Darlinghurst, New South Wales, Australia
  • Local Institution - 101 Adelaide, South Australia, Australia
  • Local Institution - 105 Box Hill, Victoria, Australia
  • Local Institution - 102 Langwarrin, Victoria, Australia
View all 107 locations
View Trial Details
Completed

Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF

NCT01644110

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Universitätsklinikum Aachen - Med. Klinik IV Aachen, Germany
  • Hämatologisch onkologische Praxis Augsburg, Germany
  • Helios Klinikum Bad Saarow Bad Saarow, Germany
  • Klinik für Innere Medizin Uniklinik Köln Cologne, Germany
View all 17 locations
View Trial Details

Related conditions